About Our Team
Helping to improve patient care and outcomes
with products that provide early and specific
insights into clinical conditions.
Peter Mørch Eriksen
Peter Mørch Eriksen was appointed CEO of BioPorto in July 2013. Peter Mørch Eriksen has more than 20 years of experience within medtech/life science in Denmark and abroad. Prior to joining BioPorto, Peter Mørch Eriksen was CEO of Sense A/S and before this, he held positions as Vice President of Medtronic in both the USA and Denmark. From these positions, Peter Mørch Eriksen brings extensive experience in creating growth, restructuring and funding in technology intensive and complex companies. Peter Mørch Eriksen has an accounting background supplemented with courses in management. In addition to being CEO of BioPorto, Peter Mørch Eriksen chairs the board of FluoGuide, member of Lund University Advisory Board, and Director of PMEconsult ApS. He also serves on the Medical Device and Diagnostics Advisory Committee of Cincinnati Children’s Hospital Medical Center in Ohio, US.
Amy Winslow was appointed President of BioPorto Diagnostics, Inc. in April 2019. She is an experienced diagnostics executive, who most recently served as President and CEO of Magellan Diagnostics, a Boston-based point-of-care diagnostics company. While at Magellan, Amy Winslow led the company’s restructuring for growth, increased profitability, built a dedicated commercial team, and ultimately ran a successful sale of the company to Meridian Bioscience, Inc. Prior to Magellan, among other roles, Amy Winslow served as VP Marketing for Athena Diagnostics, a neurodiagnostic specialty laboratory testing business that was later acquired by Quest Diagnostics. Amy Winslow has an MBA from Harvard Business School and a BA in Biology from Brown University.
Vice President of Business Development
John is an experienced sales and marketing leader in the biotech, medical device and diagnostics industries. Before joining BioPorto, John served as Vice President of Sales at Critical Diagnostics where he was instrumental in launching their novel cardiac biomarker ST2. Throughout his career, John has held many senior sales and marketing roles including 14 years as Director of Global Marketing at Abbott Diagnostics. John has a MSc in Pharmacology from New York Medical College and a BS in Biology from Springfield College.
Vice President of US Sales
Jennifer excels at leading sales organizations through change such as growth, new markets, product launches and team integrations. Focusing on process and system improvements and developing methods and teams to consistently achieve revenue goals is the key to her success. Jennifer’s sales career has spanned both medical and high tech; she has a Masters Certificate from Wayne State and a Bachelor of Science from Alma College.